» Articles » PMID: 21756998

Microarray Analyses of Laser-captured Hippocampus Reveal Distinct Gray and White Matter Signatures Associated with Incipient Alzheimer's Disease

Overview
Date 2011 Jul 16
PMID 21756998
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative disorder that threatens to reach epidemic proportions as our population ages. Although much research has examined molecular pathways associated with AD, relatively few such studies have focused on the disease's critical early stages. In a prior microarray study we correlated gene expression in hippocampus with degree of Alzheimer's disease and found close associations between upregulation of apparent glial transcription factor/epigenetic/tumor suppressor genes and incipient AD. The results suggested a new model in which AD pathology spreads along myelinated axons (Blalock et al., 2004). However, the microarray analyses were performed on RNA extracted from frozen hand-dissected hippocampal CA1 tissue blocks containing both gray and white matter, limiting the confidence with which transcriptional changes in gray matter could be distinguished from those in white matter. Here, we used laser capture microdissection (LCM) to exclude major white matter tracts while selectively collecting CA1 hippocampal gray matter from formalin-fixed, paraffin-embedded (FFPE) hippocampal sections of the same subjects assessed in our prior study. Microarray analyses of this gray matter-enriched tissue revealed many transcriptional changes similar to those seen in our past study and in studies by others, particularly for downregulated neuron-related genes. Additionally, the present analyses identified several previously undetected pathway alterations, including downregulation of molecules that stabilize ryanodine receptor Ca2+ release and upregulation of vasculature development. Conversely, we found a striking paucity of the upregulated changes in the putative glial and growth-related genes that had been strongly overrepresented in the prior mixed-tissue study. We conclude that FFPE tissue can be a reliable resource for microarray studies of brain tissue, that upregulation of growth-related epigenetic/transcription factors during incipient AD is predominantly localized in and around white matter (supporting our prior findings and model), and that novel alterations in vascular and ryanodine receptor-related pathways in gray matter are closely associated with incipient AD.

Citing Articles

Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue.

Heberle B, Fox K, Libermann L, Xavier S, Dallarosa G, Santos R Alzheimers Dement. 2025; 21(3):e70025.

PMID: 40042520 PMC: 11881636. DOI: 10.1002/alz.70025.


Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications.

Hatzimanolis O, Sykes A, Cristino A Mol Psychiatry. 2025; .

PMID: 39966624 DOI: 10.1038/s41380-025-02925-1.


Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue.

Heberle B, Fox K, Libermann L, Xavier S, Dallarosa G, Santos R bioRxiv. 2024; .

PMID: 39574617 PMC: 11580990. DOI: 10.1101/2024.11.07.622520.


Leveraging Diverse Regulated Cell Death Patterns to Identify Diagnosis Biomarkers for Alzheimer's Disease.

Ren L, Zhang Q, Zhou J, Wang X, Zhu D, Chen X J Prev Alzheimers Dis. 2024; 11(6):1775-1788.

PMID: 39559889 PMC: 11573840. DOI: 10.14283/jpad.2024.119.


The lemur tail kinase family in neuronal function and disfunction in neurodegenerative diseases.

Larose A, Miller C, Morotz G Cell Mol Life Sci. 2024; 81(1):447.

PMID: 39520508 PMC: 11550312. DOI: 10.1007/s00018-024-05480-0.


References
1.
Mucke L, Masliah E, Yu G, Mallory M, Rockenstein E, Tatsuno G . High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000; 20(11):4050-8. PMC: 6772621. View

2.
Mrak R, Griffin W . Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging. 2002; 22(6):903-8. DOI: 10.1016/s0197-4580(01)00287-1. View

3.
Burger C . Region-specific genetic alterations in the aging hippocampus: implications for cognitive aging. Front Aging Neurosci. 2010; 2:140. PMC: 2967426. DOI: 10.3389/fnagi.2010.00140. View

4.
Gibson G, Peterson C . Calcium and the aging nervous system. Neurobiol Aging. 1987; 8(4):329-43. DOI: 10.1016/0197-4580(87)90072-8. View

5.
Brinton R . Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. Adv Drug Deliv Rev. 2008; 60(13-14):1504-11. PMC: 2993571. DOI: 10.1016/j.addr.2008.06.003. View